Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Aspirin could cut cancer risk in over 40s

Aspirin could cut cancer risk in over 40s

29th April 2009

New research claims that people taking aspirin in their 40s could cut the risk of developing cancer later in life.

A study published in the Lancet Oncology suggests taking aspirin at any age before cancer begins to develop ? and for at least ten years ? would maximise the drug’s potential to prevent the fatal disease.

Researchers believe the drug blocks the effects of the COX enzymes – proteins involved in inflammation and found at unusually high levels in several types of cancer.

Study author, Professor Jack Cuzick, from the Cancer Research UK Centre for Epidemiology at Queen Mary, University of London, said: “Taking aspirin regularly in your mid 40s could maximise the effect this drug has on preventing cancer.

“Taking aspirin at this age, which is about the time pre-cancerous lesions usually begin to develop, may be the best time to stop the disease from progressing to actual cancer.”

“And, as the risk of serious side effects of aspirin greatly increase after 60 years old, taking long-term treatment before this age will help to minimise these side effects.”

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.